<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01128608</url>
  </required_header>
  <id_info>
    <org_study_id>The Effect of PCO2 Solution</org_study_id>
    <nct_id>NCT01128608</nct_id>
  </id_info>
  <brief_title>The Effect of High PCO2 Solution on Esophageal Acid Sensation</brief_title>
  <acronym>PC02</acronym>
  <official_title>The Effect of High PCO2 Solution on Esophageal Acid Sensation in Healthy Patients Versus Those With Non-Erosive Reflux Disease.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Southern Arizona VA Health Care System</agency>
      <agency_class>U.S. Fed</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Southern Arizona VA Health Care System</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effect of intraesophageal high PCO2 solution as compared to acidic and
      saline solutions on subjects' heartburn sensation using stiumlus-response functions.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Presently, the exact mechanism of GERD and the role of CO2 in pathogenesis of heartburn
      symptoms is unclear. CO2 conversion to protons may play a key role in the mechanism for
      heartburn sensation. This is a prospective, randomized study that will help further explore
      the mechanism for heartburn sensation in GERD patients and can be a prelude for further
      studies examining the role of new class antireflux agents such as carbonic anhydrase
      inhibitors in the treatment of patients with heartburn.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>September 2009</start_date>
  <completion_date type="Anticipated">November 2010</completion_date>
  <primary_completion_date type="Anticipated">October 2010</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Diagnostic</primary_purpose>
    <masking>Single (Participant)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Mechanism of GERD</measure>
    <time_frame>NA There is no exact timeframe.</time_frame>
    <description>Presently the exact mechanism of GERD and the role of CO2 in pathogenesis of heartburn sysmptoms is unclear. We aim to compare the effect of intraesophageal high PCO2 solution with saline solution on heartburn sensation.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">20</enrollment>
  <condition>Gastroesophageal Reflux Disease</condition>
  <arm_group>
    <arm_group_label>Control Group - Healthy Subjects</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Healthy volunteers with normal EGD.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>NERD Group</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects with NERD. Heartburn symp x2 wk for 3 months. Normal EGD and abnormal 24 hour pH.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>24-Hr Esohpageal pH Monitoring</intervention_name>
    <description>There will be a 24-hr pH monitoring procedure and two 10-minute infusions each one week apart consisting of high PCO2 solution and 0.1 N HCI solution.</description>
    <arm_group_label>NERD Group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>PCO2 Acid Perfusion and 0.1N HCI Perfusion</intervention_name>
    <description>A small tube will be inserted through the nostril and into the esophagus. A mild CO2 solution or a mild saline solution will be administered for aprox. 10 minutes during which you will be asked questions regarding any symptoms you may experience.</description>
    <arm_group_label>Control Group - Healthy Subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

        10 Healthy Controls

          -  Normal EGD, Normal 24-hr pH

          -  18-80 Years of age

          -  Able to read, understand and complete study questionnaires and diary

          -  Able to understand study procedures and sign informed consent

          -  Albe to comply with all study requirements

             10 NERD (Non-Erosive Reflux Disease)

          -  18-80 Years of age

          -  Willing to stop PPI/H2 Blocker prior to EGD

          -  Have heartburn symptoms 2+ times per week for at least 3 months.

        Exclusion Criteria:

          -  Esophageal erosions, Barretts, or peptic stricture on EGD

          -  Previous esophageal, gastric or duodenal surgery

          -  underlying co-morbidities

          -  Diabetes mellitus (requires insulin), scleroderms, or neuromuscular disorder

          -  Upper airway symptoms

          -  Tricyclic antidepressants, antispasmodics, selective serotonin receptor inhibitors,
             thiazides, bile acid-binding agents or prokinetics

          -  Patients who cannot or are unwilling to sign ICF
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Ronnie Fass, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Southern Arizona Veterans Health Care System</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Marcia Willis, CCRC</last_name>
    <phone>520-792-1450</phone>
    <phone_ext>2032</phone_ext>
    <email>marcia.willis@va.gov</email>
  </overall_contact>
  <location>
    <facility>
      <name>Southern Arizona VA Health Care System</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronnie Fass, M.D.</last_name>
      <phone>520-792-1450</phone>
      <phone_ext>5139</phone_ext>
      <email>ronnie.fass@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Marcia Willis, CCRC</last_name>
      <phone>792.1450</phone>
      <phone_ext>2032</phone_ext>
      <email>marcia.willis@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Ronnie Fass, M.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Southern Arizona Veterans Health Care System</name>
      <address>
        <city>Tucson</city>
        <state>Arizona</state>
        <zip>85723</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Ronnie Fass, MD</last_name>
      <phone>520-792-1450</phone>
      <phone_ext>5139</phone_ext>
      <email>ronnie.fass@va.gov</email>
    </contact>
    <contact_backup>
      <last_name>Marcia Willis, CCRC</last_name>
      <phone>520-792-1450</phone>
      <phone_ext>2032</phone_ext>
      <email>marcia.willis@va.gov</email>
    </contact_backup>
    <investigator>
      <last_name>Ronnie Fass, MD</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 21, 2010</study_first_submitted>
  <study_first_submitted_qc>May 21, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 24, 2010</study_first_posted>
  <last_update_submitted>July 20, 2010</last_update_submitted>
  <last_update_submitted_qc>July 20, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">July 21, 2010</last_update_posted>
  <responsible_party>
    <name_title>Ronnie Fass, M.D.</name_title>
    <organization>Southern Arizona VA Health Care System</organization>
  </responsible_party>
  <keyword>GERD</keyword>
  <keyword>Heartburn</keyword>
  <keyword>Acid Reflux</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Gastroesophageal Reflux</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <pending_results>
    <submitted>March 17, 2011</submitted>
    <returned>April 12, 2011</returned>
    <submitted>April 13, 2011</submitted>
    <returned>May 6, 2011</returned>
    <submitted>May 11, 2011</submitted>
    <returned>June 9, 2011</returned>
  </pending_results>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

